TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataEC50: 3.80E+3nMAssay Description:Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activationMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataEC50: 1.70E+3nMAssay Description:Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activationMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataEC50: 1.00E+3nMAssay Description:Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activationMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataEC50: 5.30E+3nMAssay Description:Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activationMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataEC50: 3.50E+3nMAssay Description:Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activationMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataEC50: 1.90E+3nMAssay Description:Agonist activity at ionomycin-stimulated TRPV3 (unknown origin) activationMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 130nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:Antagonist activity at human TRPV3 expressed in recombinant HEK293 cells assessed as inhibition of 2-APB induced calcium flux by FLIPR analysisMore data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 180nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:TRPV3 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:TRPV3 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:TRPV3 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:TRPV3 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:TRPV3 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:TRPV3 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:TRPV3 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:TRPV3 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:TRPV3 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 220nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 220nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 230nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 250nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 260nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 270nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 3(Human)
Scientus Pharma
Curated by ChEMBL
Scientus Pharma
Curated by ChEMBL
Affinity DataIC50: 280nMAssay Description:Experiments were conducted using the FLIPRTETRA . On the day prior to the experiment, recombinant HEK293 cells that stably express human and mouse TR...More data for this Ligand-Target Pair
